| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 07/07/2004 | CN1511146A Preparation of taxus alkane derivative |
| 07/07/2004 | CN1511143A Herbicidal substituted benzoylpyrazoles |
| 07/07/2004 | CN1511034A Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/06/2004 | US6759538 Substituted diphenyl heterocycles useful for treating HCV infection |
| 07/06/2004 | US6759425 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
| 07/06/2004 | US6759420 Low molecular weight, factor xa specific blood clotting inhibitors without side effects |
| 07/06/2004 | US6759419 Pyrrolidinone derivatives, their preparation and pharmaceutical composition comprising the same |
| 07/06/2004 | US6759411 Heterocyclic piperidines as modulators of chemokine receptor activity |
| 07/06/2004 | US6759409 Inhibitors of papilloma virus |
| 07/06/2004 | CA2119556C Substituted aryl- and heteroaryl-phenyloxazolidinones |
| 07/06/2004 | CA2105822C Herbicidal 4-heteroaroylisoxazole derivatives |
| 07/06/2004 | CA2085201C New pyridyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/01/2004 | WO2004055015A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | WO2004055012A1 Indane compounds as ccr5 antagonists |
| 07/01/2004 | WO2004055011A1 Heterocyclic compounds as ccr5 antagonists |
| 07/01/2004 | WO2004055010A2 Cyclopropyl compounds as ccr5 antagonists |
| 07/01/2004 | WO2004055007A1 3-substituted-4-pyrimidone derivatives |
| 07/01/2004 | WO2004054999A1 Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
| 07/01/2004 | WO2004054987A1 Cathepsin cysteine protease inhibitors and their use |
| 07/01/2004 | WO2004054984A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion |
| 07/01/2004 | WO2004054624A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands |
| 07/01/2004 | WO2004054581A2 Cyclohexyl compounds as ccr5 antagonists |
| 07/01/2004 | WO2004026306A3 Pyrazole derivatives as transforming growth factor (tgf) inhibitors |
| 07/01/2004 | WO2004017911A3 Protease inhibitors |
| 07/01/2004 | WO2004012656A3 Thiophene and furan derivatives as prostaglandin agonists and use thereof |
| 07/01/2004 | WO2003096984A3 Drug therapy for celiac sprue |
| 07/01/2004 | WO2003093297A3 Protein kinase modulators and methods of use |
| 07/01/2004 | US20040127733 adrenergic blocking agents; for treatment of diabetes/obesity |
| 07/01/2004 | US20040127708 antiviral activities; aids treatment |
| 07/01/2004 | US20040127707 Novel phthalazinones |
| 07/01/2004 | US20040127536 Indazole Derivatives |
| 07/01/2004 | US20040127530 treating gram-negative microbial infections |
| 07/01/2004 | US20040127527 Large conductance calcium-activated k channel opener |
| 07/01/2004 | US20040127515 For therapy of hypertension, chronic obstructive pulmonary disease, organ damage, pain, diabetic nephropathy, dementia |
| 07/01/2004 | US20040127502 Use of pyrimidine compound galanin receptor subtype 3 (GAL3) antagonists, which may be classified as neutral antagonists, inverse agonists or allosteric modulators, to treat depressive disorders and/or anxiety |
| 07/01/2004 | US20040127497 Pyridyl substituted heterocycles useful for treating or preventing HCV infection |
| 07/01/2004 | US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome |
| 07/01/2004 | US20040127492 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | US20040127426 Peptidic compounds as cysteine protease inhibitors |
| 07/01/2004 | US20040127382 activity of peroxy compounds in washing, bleaching and cleaning processes at low temperature is increased by the transition metal complexes |
| 07/01/2004 | US20040123948 Adjust adhesion at interface of microelectronics packages; shrinkage inhibition |
| 07/01/2004 | DE10259933A1 Substituierte 4-Aryl-Pyridine 4-aryl-substituted pyridines |
| 07/01/2004 | DE10259407A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis |
| 07/01/2004 | CA2549463A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands |
| 07/01/2004 | CA2509244A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | CA2508838A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion |
| 07/01/2004 | CA2507629A1 Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
| 06/30/2004 | EP1433788A1 Pyrazole-derivatives as factor Xa inhibitors |
| 06/30/2004 | EP1433786A1 Benzoxazole compound and pharmaceutical composition containing the compound |
| 06/30/2004 | EP1433783A2 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 06/30/2004 | EP1432706A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 06/30/2004 | EP1432705A2 Dual action antibiotics |
| 06/30/2004 | EP1432701A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 06/30/2004 | EP1432698A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 06/30/2004 | EP1432696A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 06/30/2004 | EP1432694A1 Stereospecific process for the synthesis of 2-yl chroman derivatives |
| 06/30/2004 | EP1432693A2 Mch receptor antagonists |
| 06/30/2004 | EP1432691A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 06/30/2004 | EP1432690A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 06/30/2004 | EP1432689A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
| 06/30/2004 | EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 06/30/2004 | EP1432420A2 Benzimidazolidinone derivatives as muscarinic agents |
| 06/30/2004 | EP1432417A2 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 06/30/2004 | EP1432416A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 06/30/2004 | EP1432313A1 N-thio-nicotinamide derivatives and related compounds for use as pesticides |
| 06/30/2004 | EP1080081B1 Benzofuroxan derivatives and their use in treating angina pectoris |
| 06/30/2004 | CN1509281A Benzimidazol derivatives modulate che mokine receptors |
| 06/30/2004 | CN1509278A N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound |
| 06/30/2004 | CN1509275A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509274A Metallo proteinase inhibitors |
| 06/30/2004 | CN1509273A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509173A Carboxylic and substituted oxazole derivatives for use as PPAR-& and PPAR-r activators in the treatment of diabetes |
| 06/30/2004 | CN1155596C New phenylpiperazines |
| 06/30/2004 | CN1155590C Chromone compounds with antineoplastic activity and its open-loop products and preparing process |
| 06/29/2004 | US6756406 Antiarthritic agents; rheumatic diseases; osteoarthritis; inhibition of the inducible nitric oxide synthase - induced after activation of vascular smooth muscle, macrophages, endothelial cells by enotoxin and cytokines |
| 06/29/2004 | US6756378 VLA-4 inhibitor compounds |
| 06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
| 06/29/2004 | US6756370 Piperidine alcohols |
| 06/29/2004 | US6756367 Useful in the treatment of any state with increased endogenous level of corticotropin releasing hormone(crf) or hpa (hypothalamic pituitary axis) is disregulated or diseases induced by crf, including inflammatory disorders, anxiety etc |
| 06/29/2004 | CA2207404C Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase |
| 06/29/2004 | CA2205384C Dihydropyrimidines and uses thereof |
| 06/29/2004 | CA2171827C Use of thiazolidinediones to prevent or delay onset of niddm |
| 06/24/2004 | WO2004052887A2 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 06/24/2004 | WO2004052886A1 Indol derivatives and their use as 5-ht ligands |
| 06/24/2004 | WO2004052880A1 Pyridine derivatives as jnk inhibitors and their use |
| 06/24/2004 | WO2004052871A1 Benzomorpholine derivatives |
| 06/24/2004 | WO2004052869A1 5-substituted-pyrazine or pyridine glucokinase activators |
| 06/24/2004 | WO2004052868A1 Pyrazine-based tubulin inhibitors |
| 06/24/2004 | WO2004052864A1 Pyrazole and imidazole compounds and uses thereof |
| 06/24/2004 | WO2004052861A1 Hydroxyalkylated cyclic diamine compound |
| 06/24/2004 | WO2004052852A1 3-pyrrolyl urea derivatives and their use as antiviral agents |
| 06/24/2004 | WO2004052851A1 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa |
| 06/24/2004 | WO2004052373A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k |
| 06/24/2004 | WO2004052372A1 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction |
| 06/24/2004 | WO2004052366A1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 06/24/2004 | WO2004052280A2 Anti-angiogenic compounds and their use in cancer treatment |
| 06/24/2004 | WO2004037807A3 Medicinal arylethanolamine compounds |
| 06/24/2004 | WO2004019869A3 Indoles having anti-diabetic activity |
| 06/24/2004 | WO2004018044A8 N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent |